Portal Diabetes, Inc.

Portal Diabetes, Inc. is a medical technology company founded in 2013, focused on developing a fully automatic, implantable insulin pump system for individuals with insulin-dependent diabetes. Originally named PhysioLogic Devices, Inc., the company rebranded and moved its headquarters to Westfield, Indiana, in 2024. The flagship product, the Portal Pump, is an innovative insulin delivery system that works with a glucose sensor to provide automated and continuous insulin regulation. This system mimics natural insulin physiology by delivering insulin directly into the abdomen, functioning effectively as an artificial pancreas. With the ability to store up to 12 weeks of insulin, the Portal Pump offers users greater freedom from the frequent dosing and monitoring required by traditional therapies. Portal Diabetes aims to enhance the quality of life for those managing diabetes by simplifying insulin therapy. The company is committed to advancing medical technology in diabetes care and has filed multiple patents related to insulin therapies and microfluidic device technology.

• Employees 26
• Founded 2013
• Annual Revenue $2200000